期刊文献+

脉搏轮廓持续心输出量监测在急性左心衰竭治疗中的指导价值 被引量:4

The Guiding Value of Monitoring With Pulse-induced Contour Cardiac Output in Treatment of Acute Left Heart Failure
下载PDF
导出
摘要 目的:探讨脉搏轮廓持续心输出量(PICCO)在急性左心衰竭的血液净化(CBP)治疗中的目标导向性作用。方法:回顾性研究因急性左心衰竭出现呼吸衰竭需行机械通气的患者12例(联合组),在内科治疗基础上给予PiCCO监测下CBP治疗,比较治疗前后APACHEⅡ评分,容量指标(ITBVI、GEDVI、EVLWI)和心功能指数(CFI)。同时将该组患者和因相同疾病进行机械通气治疗的患者14例(常规组)进行比较,比较28d病死率、机械通气时间、住ICU时间,APACHEⅡ评分。结果:联合组在治疗后APACHEⅡ评分改善,ITBVI、GEDVI、EVLWI恢复正常,CFI改善;联合组病死率、机械通气时间、住ICU时间、APACHEⅡ评分均优于常规组。结论:CBP是治疗急性左心衰竭有效方法,而PiCCO为这种治疗提供了有效的指导。 Objective: To investigate the target directed effects of monitoring with pulse-induced contour cardiac output ( PiCCO) in treatment of acute left heart failure ( ALHF) by continuous blood purification ( CBP) . Methods: Twelve Cases ( combination group) with ALHF who developed respiratory failure requiring mechanical ventilation were retrospectively analyzed. On the basis of the medical treatment,patients were given CBP under the monitoring of PICCO. APACHE Ⅱ score, the capacity indicators ( ITBVI,GEDVI,EVLWI) and cardiac function index ( CFI) were compared before and after treatments. Meanwhile,28-day mortality rate,mechanical ventilation time,time of ICU stay and APACHEⅡ score were compared between patients of combination group and the other fourteen patients ( conventional group) with the same disease. Results: APACHE Ⅱ score was improved after treatments,ITBVI,GEDVI and EVLWI were returned to normal,and CFI was improved in combination group. The mortality rate,mechanical ventilation time,time of ICU stay and APACHE Ⅱ scores of combination group were superior to those of the conventional group. Conclusions: CBP is an effective means in treatment of ALHF,and PiCCO provides effective guidance for this treatment.
作者 李韫 李杰
出处 《内科急危重症杂志》 2011年第6期356-357,377,共3页 Journal of Critical Care In Internal Medicine
关键词 持续血液净化 脉波指示剂连续心排血量 急性左心衰竭 Continuous blood purification Pulse indicator continuous cardiac output Acute left heart failure
  • 相关文献

参考文献9

  • 1Nieminen MS, Bohm M, Cowie MR. (2005) ESC Committee for Practice Guideline (CPG). Executive sunnnary of the guidelines on the diagnosis and treatment of acute heart failure:The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005,26:584.
  • 2Alain Fischer. Human primary immunodeficiency diseases: a perspective. Nat Immunol, 2004,5:23-30.
  • 3Chapel H, Geha R, Rosen F. Primary immunodeficiency diseases:an update. Clin Exp Immunol,2003,132:9-15CDC.
  • 4Ochs HD, Smith CIE, Puck JM. Primary immunodeficency diseases.New York:Oxford University Press, 1999. 459-488.
  • 5Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies:report of the European experience 1968 - 99. Lancet, 2003,361:553-560.
  • 6Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med, 2002,346:1185-1193.
  • 7Hacein-Bey-Abina S, yon Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med, 2003,348:255-256.
  • 8马胜银,刘朝阳.连续性肾脏替代疗法在治疗伴急性肾衰竭的多器官功能障碍综合征中的应用[J].中国危重病急救医学,2003,15(2):97-99. 被引量:56
  • 9Applying public health strategies to primary immunodeficiency diseases: A potential approach to geneticdisorders. 2004, 6. 1st available from: URL: http://www. cdc. gov/genomics/ info/conference/Plsynop. htm

二级参考文献5

共引文献56

同被引文献37

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部